IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 194 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Prevalence and predictors of potential drug–drug interactions in patients of internal medicine wards of a tertiary care hospital in India
Yugandhar Bethi,Deepak Gopal Shewade,Tarun Kumar Dutta,Batmanabane Gitanjali
European Journal of Hospital Pharmacy.2018;25(6)317
2Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
Abdullah K. Rabba,Ayeshe M. Abu Hussein,Bayan K. Abu Sbeih,Somaya I. Nasser
BioMed Research International.2020;2020(6)1
3Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
Subish Palaian
BioMed Research International.2020;2020(6)335
4Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency
Pengqiang Du,Aifeng Wang,Yongcheng Ma,Ao Jia,Yafei Li,Xingang Li
Clinical Therapeutics.2020;42(9)1799
5Involvement of pregnane X receptor in the suppression of carboxylesterases by metformin in vivo and in vitro, mediated by the activation of AMPK and JNK signaling pathway
Enfang Shan,Zhu Zhu,Shuangcheng He,Dongbao Chu,Dinghao Ge,Yunran Zhan,Wei Liu,Jian Yang,Jing Xiong
European Journal of Pharmaceutical Sciences.2017;102(9)14
6Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Netsanet Diksis,Tsegaye Melaku,Desta Assefa,Andualem Tesfaye
SAGE Open Medicine.2019;7(9)205031211985735
7Drug–drug interactions in patients with acute coronary syndrome across phases of treatment
Ana V. Pejcic,Slobodan M. Jankovic,Goran Davidovic
Internal and Emergency Medicine.2019;14(3)411

Clinical Pharmacy Education and Practice in Nepal: A Glimpse into Present Challenges and Potential Solutions

Sunil Shrestha,Deepa Shakya,Subish Palaian
Advances in Medical Education and Practice.2020;Volume 11(3)541
9Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Zarka Akbar,Sundas Rehman,Asad Khan,Amjad Khan,Muhammad Atif,Nafees Ahmad
Journal of Pharmaceutical Policy and Practice.2021;14(1)541
10Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases
Natália da Palma Sobrinho,Juliana Faria Campos,Rafael Celestino da Silva
Revista Brasileira de Enfermagem.2020;73(5)541
11Prevalencia de potenciales interacciones farmacológicas de Azitromicina en Colombia, 2012-2013
Jorge Enrique Machado Alba,Dayron Martinez,Daniela Gomez-Suta
Revista de Salud Pública.2015;17(3)463
12The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients
Kaloyan D. Georgiev,Nadezhda Hvarchanova,Marieta Georgieva,Branimir Kanazirev
International Journal of Clinical Pharmacy.2019;41(6)1555
13Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients
Ghulam Murtaza,Muhammad Yasir Ghani Khan,Saira Azhar,Shujaat Ali Khan,Tahir M. Khan
Saudi Pharmaceutical Journal.2016;24(2)220
14A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin
Aurel C.E. Allabi,Yessoufou Tchabi,Murielle Hounkponou,Rebecca Quenum,Jeanne Vehounkpe-Sacca
Current Drug Safety.2020;15(3)190
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow